Danaher Corp
Close on Oct 30, 2026Market cap $163.25BP/E 41.2Yield –
Danaher Base Business Core Sales Growth by Year
Base Business Core Sales Growth (Legacy FY2021Q4–FY2023Q4: Base Business ex-COVID Testing & Vx/Tx) (%)
Danaher Base Business Core Sales Growth: -0.5% in FY2023, down 15.0 pts from a year earlier. No newer figure appears in the documents we track.
Where the FY2023 figure comes from
Source: Danaher IR — nongaap_2023Q4 ↗
Historical (Legacy) series reported continuously from Q4 2021 to the Q1 2024 definition break (when COVID transitioned to an endemic phase and the company ceased separately breaking out COVID vaccines/therapeutics).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Base Business Core Sales Growth (Legacy FY2021Q4–FY2023Q4: Base Business ex-COVID Testing & Vx/Tx) (%) | Year on year | Source |
|---|---|---|---|---|
| FY2023 | Dec 31, 2023 | -0.5% | -15.0 pts | Danaher IR — nongaap_2023Q4 ↗ |
| FY2022 | Dec 31, 2022 | 14.5% | – | Danaher IR — nongaap_ex_veralto ↗ |
Cite this data
StockData. (2026). Danaher Base Business Core Sales Growth (%), annual FY2022–FY2023 [Data set]. Compiled from Danaher SEC filings and investor materials. https://stockdatahq.com/stocks/dhr/kpis/base-biz-core-growth-legacy-total
See every metric in the Danaher KPI table. Data updated Nov 2, 2026.